812 Non-Hodgkin's lymphoma of intermediate degree. 13-year follow-up of 89 patients treated with chop
✍ Scribed by A. Murias; José Aguiar; José Almenarez; F. Molano; U. Bohn; P. Betancor; M. Sosa
- Book ID
- 116167558
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 149 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND Doxorubicin cardiotoxicity is one of the most serious side effects of the cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy, regimen, especially among elderly patients. In the CEOP regimen, epirubicin was substituted for doxorubicin to reduce cardiot
This is an analysis of the long-term follow-up data of 99 patients receiving HOAP-Bleo, IMVP-16 and PAC as salvage chemotherapy for refractory or relapsed intermediate or high grade non-Hodgkin's lymphomas. Most of the patients received HOAP-Bleo or PAC following failure of initial chemotherapy and